STOCKS TO BUY: We have identified several stocks that can potentially TRIPLE. Learn more!

Genomic Health Inc. (GHDX)

NASDAQ: Health Care

Get a 5-page Ratings Report on (GHDX) now
$33.55 -0.50 | -1.47%
Today's Range: 33.20 - 33.95
GHDX Avg. Daily Volume: 244,700
06/19/13 - 4:00 PM ET
 
  • Latest Dividend: N/A
  • Latest Dividend Yield: N/A
  • Dividend Ex-Date: N/A
  • Price Earnings Ratio: 162.14
  • Price Earnings Comparisons:
    GHDX Sector Avg. S&P 500
    162.14 170.30 17.70
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    19.89% -0.24% 125.20%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 14.10 0.57 0.16
    Net Income 5.10 -1.88 0.00
    EPS 0.00 -1.82 0.00
  • Earnings for GHDX:
    EBITDA 13,905,000
    REVENUE 235,173,000
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $-0.08 $0.00 $-0.06 $0.27
Number of Analysts 8 7 10 9
High Estimate $-0.05 $0.04 $0.03 $1.14
Low Estimate $-0.10 $-0.03 $-0.15 $-0.05
Prior Year $0.08 $0.11 $0.28 $-0.06
Growth Rate (Year over Year) -204.69% -98.70% -121.07% 555.74%
(GHDX) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
TRY IT FREE
New! $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,112.19 -206.04 -1.35%
NASDAQ 3,443.20 -38.98 -1.12%
S&P 500 1,628.93 -22.88 -1.39%
US 10 Yr 2.311% +0.129

Brokerage Partners

Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.

Top Rated Stocks Top Rated Funds Top Rated ETFs